KEY TAKEAWAYS The study aimed to investigate the efficacy and safety of TAS-102 in patients with fluoropyrimidine-refractory PC. The primary endpoint was to determine the PFS rate. Researchers noticed the promising efficacy and acceptable safety of TAS-102; further...
![Efficacy of TAS-102 in Fluoropyrimidine-Refractory PC](https://oncweekly.com/wp-content/uploads/2023/12/pancreatic-cancer-virus-cells-and-dna-strand-1080x675.jpeg)